Structured proxy features for multimodal NSCLC survival prediction from pretreatment CT.
Authors
Affiliations (3)
Affiliations (3)
- Department of Biomedical Informatics and Data Science, School of Medicine, The University of Alabama at Birmingham (UAB), Birmingham, AL, United States.
- Department of Computer Science, The University of Alabama at Birmingham (UAB), Birmingham, AL, United States.
- System Pharmacology and AI Research Center (SPARC), The University of Alabama at Birmingham (UAB), Birmingham, AL, United States.
Abstract
Lung cancer results in roughly 1.8 million fatalities annually worldwide, with non-small cell lung cancer (NSCLC) comprising the majority of cases. Despite advancements in treatment, survival stratification remains challenging due to intratumoral heterogeneity inadequately captured by conventional descriptors. Standard radiomic and deep learning techniques regard imaging features as independent quantities, overlooking structured interactions between tumor characteristics. We evaluate whether structured proxy features can enhance multimodal NSCLC survival prediction by augmenting pretreatment computed tomography (CT) representations, radiomics, and clinical variables with six simulation-derived features designed to capture interactions between heterogeneity and morphology. A radiomic-parameterized cellular automaton generates growth-rate and necrosis-ratio proxy features from baseline CT by using entropy and sphericity to compute low-dimensional proxy parameters. The imaging backbone is a Transformer-based Masked Autoencoder (TMAE), which was chosen after a systematic evaluation with alternative encoders within the same pipeline and provides attention-based visualizations that highlight tumor regions receiving higher model attention. On the public Lung1 cohort (<i>n</i> = 390), the primary four-modality fusion attained a C-index of 0.641 (iAUC 0.731, log-rank <i>p</i> < 0.001). The primary result compares favorably with prior multimodal results on Lung1 (C-index 0.631; iAUC 0.592 [15]) under a comparable evaluation protocol, while a separate exploratory coefficient-optimization analysis achieved a best observed C-index of 0.662 (iAUC 0.748). These results indicate that, in addition to conventional radiomic, deep, and clinical representations within the Lung1 benchmark, simulation-derived proxy features may provide complementary predictive information within this fixed Lung1 benchmark. By integrating structured tumor-dynamics-inspired descriptors with modern volumetric CT representations, the framework provides a practical approach for retrospective relative risk ranking from routinely acquired pretreatment imaging and establishes a foundation for future repeated-split, external-cohort, and calibration studies.